These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

722 related items for PubMed ID: 18662898

  • 1. A study of the effect of splenectomy on hepatic functional reserve and structural damage in patients with chronic hepatitis C virus infection by non-invasive serum markers. A prospective study.
    Elsebae MM, Abu-Zekri NB.
    Int J Surg; 2008 Oct; 6(5):362-6. PubMed ID: 18662898
    [Abstract] [Full Text] [Related]

  • 2. Noninvasive serum markers in the diagnosis of structural liver damage in chronic hepatitis C virus infection.
    Parise ER, Oliveira AC, Figueiredo-Mendes C, Lanzoni V, Martins J, Nader H, Ferraz ML.
    Liver Int; 2006 Nov; 26(9):1095-9. PubMed ID: 17032410
    [Abstract] [Full Text] [Related]

  • 3. Is there any non-invasive marker replace the needle liver biopsy predictive for liver fibrosis, in patients with chronic hepatitis?
    Vardar R, Vardar E, Demiri S, Sayhan SE, Bayol U, Yildiz C, Postaci H.
    Hepatogastroenterology; 2009 Nov; 56(94-95):1459-65. PubMed ID: 19950810
    [Abstract] [Full Text] [Related]

  • 4. [The diagnostic value of serum hyaluronic acid, 7S domain of type IV collagen and AST/ALT ratio as markers of hepatic fibrosis in chronic hepatitis B and cirrhosis patients].
    Park JH, Park CK, Kim ES, Park SY, Jo CM, Tak WY, Kweon YO, Kim SK, Choi YW.
    Taehan Kan Hakhoe Chi; 2003 Jun; 9(2):79-88. PubMed ID: 12824747
    [Abstract] [Full Text] [Related]

  • 5. [Comparison of various noninvasive serum markers of liver fibrosis in chronic viral liver disease].
    Kim SM, Sohn JH, Kim TY, Roh YW, Eun CS, Jeon YC, Han DS, Oh YH.
    Korean J Hepatol; 2009 Dec; 15(4):454-63. PubMed ID: 20037264
    [Abstract] [Full Text] [Related]

  • 6. Serum markers for necroinflammatory activity in patients with chronic viral hepatitis and normal or mildly elevated aminotransferase levels.
    Cheong JY, Kim DJ, Hwang SG, Yang JM, Kim YB, Park YN, Cho SW.
    Liver Int; 2011 Oct; 31(9):1352-8. PubMed ID: 21745311
    [Abstract] [Full Text] [Related]

  • 7. Serum fibrosis markers identify patients with mild and progressive hepatitis C recurrence after liver transplantation.
    Carrión JA, Fernández-Varo G, Bruguera M, García-Pagán JC, García-Valdecasas JC, Pérez-Del-Pulgar S, Forns X, Jiménez W, Navasa M.
    Gastroenterology; 2010 Jan; 138(1):147-58.e1. PubMed ID: 19786026
    [Abstract] [Full Text] [Related]

  • 8. Apoptotic cytokeratin 18 neoepitopes in serum of patients with chronic hepatitis C.
    Kronenberger B, Wagner M, Herrmann E, Mihm U, Piiper A, Sarrazin C, Zeuzem S.
    J Viral Hepat; 2005 May; 12(3):307-14. PubMed ID: 15850472
    [Abstract] [Full Text] [Related]

  • 9. Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation.
    Toniutto P, Fabris C, Bitetto D, Falleti E, Avellini C, Rossi E, Smirne C, Minisini R, Pirisi M.
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1904-8. PubMed ID: 17914968
    [Abstract] [Full Text] [Related]

  • 10. Prospective comparison of six non-invasive scores for the diagnosis of liver fibrosis in chronic hepatitis C.
    Leroy V, Hilleret MN, Sturm N, Trocme C, Renversez JC, Faure P, Morel F, Zarski JP.
    J Hepatol; 2007 May; 46(5):775-82. PubMed ID: 17321634
    [Abstract] [Full Text] [Related]

  • 11. Serum adipokine levels in chronic liver diseases: association of resistin levels with fibrosis severity.
    Tsochatzis E, Papatheodoridis GV, Hadziyannis E, Georgiou A, Kafiri G, Tiniakos DG, Manesis EK, Archimandritis AJ.
    Scand J Gastroenterol; 2008 May; 43(9):1128-36. PubMed ID: 18609175
    [Abstract] [Full Text] [Related]

  • 12. Non-invasive models for predicting histology in patients with chronic hepatitis B.
    Wai CT, Cheng CL, Wee A, Dan YY, Chan E, Chua W, Mak B, Oo AM, Lim SG.
    Liver Int; 2006 Aug; 26(6):666-72. PubMed ID: 16842322
    [Abstract] [Full Text] [Related]

  • 13. Validation of three non-invasive markers in assessing the severity of liver fibrosis in chronic hepatitis C.
    Shaikh S, Memon MS, Ghani H, Baloch GH, Jaffery M, Shaikh K.
    J Coll Physicians Surg Pak; 2009 Aug; 19(8):478-82. PubMed ID: 19651008
    [Abstract] [Full Text] [Related]

  • 14. Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis.
    Parés A, Deulofeu R, Giménez A, Caballería L, Bruguera M, Caballería J, Ballesta AM, Rodés J.
    Hepatology; 1996 Dec; 24(6):1399-403. PubMed ID: 8938169
    [Abstract] [Full Text] [Related]

  • 15. Clinical presentation of chronic hepatitis C in patients with end-stage renal disease and on hemodialysis versus those with normal renal function.
    Hu KQ, Lee SM, Hu SX, Xia VW, Hillebrand DJ, Kyulo NL.
    Am J Gastroenterol; 2005 Sep; 100(9):2010-8. PubMed ID: 16128946
    [Abstract] [Full Text] [Related]

  • 16. The APRI may be enhanced by the use of the FIBROSpect II in the estimation of fibrosis in chronic hepatitis C.
    Snyder N, Nguyen A, Gajula L, Soloway R, Xiao SY, Lau DT, Petersen J.
    Clin Chim Acta; 2007 Jun; 381(2):119-23. PubMed ID: 17442291
    [Abstract] [Full Text] [Related]

  • 17. Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C.
    Lackner C, Struber G, Liegl B, Leibl S, Ofner P, Bankuti C, Bauer B, Stauber RE.
    Hepatology; 2005 Jun; 41(6):1376-82. PubMed ID: 15915455
    [Abstract] [Full Text] [Related]

  • 18. Hyaluronic acid and aspartate aminotransferase levels normalized by liver function can reflect sinusoidal impairment in chronic liver disease.
    Testa E, Malfatti F, Milazzo S, Cordiviola C, Cotellessa T, Marabotto E, Giannini E, Ceppa P, Mamone M, Risso D, Testa R.
    Liver Int; 2006 May; 26(4):439-44. PubMed ID: 16629647
    [Abstract] [Full Text] [Related]

  • 19. Decrease of type IV collagen and TIMP-1 serum levels after splenectomy in patients with schistosomiasis mansoni.
    Wyszomirska RM, Lacet Cda C, Tenório LR, Nishimura NF, Mesquita MA, Neto JB, Oliveira F, Balwani Mdo C, Almeida JR, Soares EC.
    Acta Trop; 2006 Mar; 97(3):301-8. PubMed ID: 16445881
    [Abstract] [Full Text] [Related]

  • 20. Optimized cutoffs improve performance of the aspartate aminotransferase to platelet ratio index for predicting significant liver fibrosis in human immunodeficiency virus/hepatitis C virus co-infection.
    Carvalho-Filho RJ, Schiavon LL, Narciso-Schiavon JL, Sampaio JP, Lanzoni VP, Ferraz ML, Silva AE.
    Liver Int; 2008 Apr; 28(4):486-93. PubMed ID: 18339075
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.